Table 1 Data elements
Participant | Age (years) | Race/ Ethnicity | Income range | Employment/Disability status | BMI | Mode of onset | Duration of illness (years) | Fatigue severity (0=none, 100=severe) | Muscle pain severity (0=none, 100=severe) | Joint pain severity (0=none, 100=severe) | Sleep quality (0=poor, 100=good) | Multi-dimensional fatigue inventory MFI-20§ | Fatigue severity scale§ | HADS: Depression Sub-score | Meets FM criteria | Co-morbid conditions | Medications |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 54 | Caucasian | $10,000-19,999 | Not reported | 18 | Acute | 35 | 61 | 50 | 46 | 39 | 88 | 6.67 | 6 | Yes | Osteoarthritis | Aspirin, Levothyroxine |
2 | 53 | Caucasian | $20,000-29,999 | Retired/Disablility | 31.6 | Acute | 15 | 73 | 71 | 70 | 52 | 96 | 6.78 | 13 | Yes | Hypothyroid, High Blood Pressure | Alprazolam, Amlodipine, Levothyroxine, Valganciclovir†, Naproxen, Melatonin, Aspirin, Estradiol |
3 | 53 | Caucasian | Not reported | Retired | 25.2 | Gradual | 30 | 80 | 60 | 41 | 65 | 76 | 6.56 | 6 | Yes | Degenerate Arthritis, Spinal Stenosis, Sleep Apnea | Estradiol, Valganciclovir†, Lidocaine |
4 | 47 | Caucasian | less than $10,000 | Unemployed | 25.9 | Acute | 9 | 31 | 6 | 50 | 41 | 81 | 6.67 | 3 | Yes | High Cycling EBV and HHV-6, Chronic Sinus Infections, Chlamidophila Pneumonia | Loratadine, Cetirizine, Hydroxyzine, Diphenhydram, Gabapentin, 5- Hydroxytryptophan, St. John's Wort |
5 | 61 | Caucasian | $10,000-19,999 | Unemployed/Disability | 35.7 | Gradual | 7 | 50 | 33 | 32 | 37 | 94 | 7.00 | 10 | No | Graves Disease/Hypothyroid, Obesity | Bupropion, Estradiol, Fenofibrate, Levothyroxine, Valganciclovir†, Fluoxetine, Acetaminophen |
6 | 60 | Caucasian | $80,000 or more | Employed | 20.6 | Gradual | 5 | 64 | 49 | 42 | 39 | 90 | 5.89 | 11 | Yes | None | None |
7 | 51 | Caucasian | $10,000-19,999 | Disability | 23.3 | Gradual | 5 | 81 | 25 | 0 | 71 | 89 | 5.89 | 3 | Yes | None | Acyclovir††|
8 | 29 | Caucasian | $40,000-49,999 | Employed | 27.5 | Gradual | 15 | 62 | 63 | 67 | 55 | NA | NA | 0 | Yes | None | Topiramate |
9 | 55 | Caucasian | $60,000-69,999 | Retired/Disablility | 20.4 | Acute | 10 | 74 | 70 | 48 | 55 | NA | NA | 14 | Yes | None | Bupropion, Controlled-Release Morphine, Progesterone, Loratadine, Diazepam, Alprazolam, Estradiol, Sertraline, Zolpidem, Rizatriptan, Ibuprofen, Ketorolac |
10 | 62 | Caucasian | $30,000-39,99 | Not reported | 42 | Gradual | 20 | 36 | 25 | 8 | 44 | 84 | 6.56 | 3 | No | Hypothyroid, Obesity, High Blood Pressure, ADHD | Olmesartan, Bupropion, Thyroid, Estradiol, Dextroamphetamine and Amphetamine |
11 | 57 | Caucasian | $20,000-29,999 | Employed | 33.1 | NA | NA | 0 | 0 | 0 | 71 | 42 | 2.22 | 0 | No | High Blood Pressure | Amlodipine, Asprin |
12 | 48 | Caucasian | less than $10,000 | Unemployed | 23 | NA | NA | 18 | 23 | 4 | 70 | NA | NA | 1 | No | None | None |
13 | 51 | Caucasian | less than $10,000 | Employed | 21.3 | NA | NA | 30 | 7 | 19 | 54 | NA | NA | 2 | No | None | Prozac |
14 | 58 | Caucasian | less than $10,000 | Employed | 25.1 | NA | NA | 0 | 0 | 0 | 67 | NA | NA | 3 | No | None | None |
15 | 52 | Asian | Not reported | Employed | 19.7 | NA | NA | 6 | 1 | 0 | 64 | 48 | 1.88 | 0 | No | None | Proton Pump Inhibitor |
16 | 50 | Caucasian | $50,000-59,999 | Employed | 20.5 | NA | NA | 0 | 0 | 0 | 96 | 20 | 1.22 | 0 | No | None | None |
17 | 44 | Caucasian | $30,000-39,999 | Employed | 25.5 | NA | NA | 5 | 12 | 0 | 77 | 25 | 1.77 | 1 | No | None | None |
18 | 47 | African American | $80,000 or more | Employed | 31.6 | NA | NA | 19 | 9 | 1 | 80 | 28 | 1.66 | 2 | No | Borderline High Blood Pressure, High Cholesterol | Zyrtec |
19 | 61 | Caucasian | $40,000-49,999 | Retired | 24 | NA | NA | 15 | 0 | 0 | 79 | 26 | 1.77 | 1 | No | Plantar Fasciitis | Loratadine |
20 | 62 | Latina | $10,000-19,999 | Employed | 24.5 | NA | NA | 6 | 5 | 0 | 79 | 22 | 1.33 | 1 | No | None | None |